nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—ESR1—hematologic cancer	0.259	1	CbGaD
Etonogestrel—PGR—Betamethasone—hematologic cancer	0.0708	0.233	CbGbCtD
Etonogestrel—Danazol—Prednisone—hematologic cancer	0.0465	0.33	CrCrCtD
Etonogestrel—PGR—Dexamethasone—hematologic cancer	0.0412	0.136	CbGbCtD
Etonogestrel—Methyltestosterone—Prednisone—hematologic cancer	0.0332	0.236	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisolone—hematologic cancer	0.0324	0.23	CrCrCtD
Etonogestrel—Testosterone—Prednisolone—hematologic cancer	0.0289	0.205	CrCrCtD
Etonogestrel—CYP3A4—Bexarotene—hematologic cancer	0.0159	0.0523	CbGbCtD
Etonogestrel—CYP3A4—Lomustine—hematologic cancer	0.0148	0.0486	CbGbCtD
Etonogestrel—CYP3A4—Busulfan—hematologic cancer	0.0148	0.0486	CbGbCtD
Etonogestrel—PGR—ovarian follicle—hematologic cancer	0.014	0.321	CbGeAlD
Etonogestrel—CYP3A4—Thiotepa—hematologic cancer	0.0132	0.0434	CbGbCtD
Etonogestrel—ESR1—ovarian follicle—hematologic cancer	0.0109	0.251	CbGeAlD
Etonogestrel—CYP3A4—Methoxsalen—hematologic cancer	0.0102	0.0337	CbGbCtD
Etonogestrel—CYP3A4—Bortezomib—hematologic cancer	0.00974	0.0321	CbGbCtD
Etonogestrel—CYP3A4—Daunorubicin—hematologic cancer	0.00932	0.0307	CbGbCtD
Etonogestrel—CYP3A4—Cytarabine—hematologic cancer	0.00822	0.0271	CbGbCtD
Etonogestrel—CYP3A4—Teniposide—hematologic cancer	0.00809	0.0267	CbGbCtD
Etonogestrel—CYP3A4—Ifosfamide—hematologic cancer	0.00747	0.0246	CbGbCtD
Etonogestrel—CYP3A4—Imatinib—hematologic cancer	0.00714	0.0235	CbGbCtD
Etonogestrel—CYP3A4—Ruxolitinib—hematologic cancer	0.00672	0.0221	CbGbCtD
Etonogestrel—CYP3A4—Nilotinib—hematologic cancer	0.00648	0.0214	CbGbCtD
Etonogestrel—CYP3A4—Vinorelbine—hematologic cancer	0.00643	0.0212	CbGbCtD
Etonogestrel—CYP3A4—Triamcinolone—hematologic cancer	0.00588	0.0194	CbGbCtD
Etonogestrel—CYP3A4—Dasatinib—hematologic cancer	0.00573	0.0189	CbGbCtD
Etonogestrel—CYP3A4—Mitoxantrone—hematologic cancer	0.00566	0.0186	CbGbCtD
Etonogestrel—CYP3A4—Betamethasone—hematologic cancer	0.00505	0.0166	CbGbCtD
Etonogestrel—CYP3A4—Prednisolone—hematologic cancer	0.00498	0.0164	CbGbCtD
Etonogestrel—CYP3A4—Prednisone—hematologic cancer	0.0047	0.0155	CbGbCtD
Etonogestrel—CYP3A4—Irinotecan—hematologic cancer	0.00446	0.0147	CbGbCtD
Etonogestrel—CYP3A4—Vinblastine—hematologic cancer	0.00396	0.013	CbGbCtD
Etonogestrel—CYP3A4—Vincristine—hematologic cancer	0.0039	0.0128	CbGbCtD
Etonogestrel—CYP3A4—Etoposide—hematologic cancer	0.00357	0.0118	CbGbCtD
Etonogestrel—CYP3A4—Dexamethasone—hematologic cancer	0.00294	0.00966	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—hematologic cancer	0.00243	0.00802	CbGbCtD
Etonogestrel—SHBG—hematopoietic system—hematologic cancer	0.00187	0.0431	CbGeAlD
Etonogestrel—PGR—hematopoietic system—hematologic cancer	0.00169	0.0388	CbGeAlD
Etonogestrel—SHBG—gonad—hematologic cancer	0.00142	0.0327	CbGeAlD
Etonogestrel—ESR1—hematopoietic system—hematologic cancer	0.00132	0.0303	CbGeAlD
Etonogestrel—SHBG—blood—hematologic cancer	0.00124	0.0285	CbGeAlD
Etonogestrel—SHBG—bone marrow—hematologic cancer	0.0012	0.0276	CbGeAlD
Etonogestrel—PGR—blood—hematologic cancer	0.00112	0.0257	CbGeAlD
Etonogestrel—SHBG—testis—hematologic cancer	0.00103	0.0236	CbGeAlD
Etonogestrel—ESR1—gonad—hematologic cancer	0.001	0.0231	CbGeAlD
Etonogestrel—PGR—lung—hematologic cancer	0.00098	0.0225	CbGeAlD
Etonogestrel—PGR—testis—hematologic cancer	0.000925	0.0213	CbGeAlD
Etonogestrel—ESR1—blood—hematologic cancer	0.000875	0.0201	CbGeAlD
Etonogestrel—ESR1—lung—hematologic cancer	0.000767	0.0176	CbGeAlD
Etonogestrel—CYP3A4—hematopoietic system—hematologic cancer	0.000737	0.0169	CbGeAlD
Etonogestrel—ESR1—testis—hematologic cancer	0.000723	0.0166	CbGeAlD
Etonogestrel—PGR—lymph node—hematologic cancer	0.000671	0.0154	CbGeAlD
Etonogestrel—ESR1—lymph node—hematologic cancer	0.000524	0.0121	CbGeAlD
Etonogestrel—CYP3A4—blood—hematologic cancer	0.000488	0.0112	CbGeAlD
Etonogestrel—Nandrolone phenpropionate—AR—hematologic cancer	0.000367	0.107	CrCbGaD
Etonogestrel—Danazol—CCL2—hematologic cancer	0.000338	0.0983	CrCbGaD
Etonogestrel—Quinestrol—ESR1—hematologic cancer	0.000333	0.0968	CrCbGaD
Etonogestrel—Nandrolone decanoate—AR—hematologic cancer	0.000278	0.081	CrCbGaD
Etonogestrel—Mestranol—ESR1—hematologic cancer	0.000252	0.0734	CrCbGaD
Etonogestrel—Desogestrel—ESR1—hematologic cancer	0.000249	0.0725	CrCbGaD
Etonogestrel—Norgestimate—ESR1—hematologic cancer	0.000233	0.0678	CrCbGaD
Etonogestrel—Levonorgestrel—AR—hematologic cancer	0.000185	0.0539	CrCbGaD
Etonogestrel—Danazol—AR—hematologic cancer	0.000169	0.0491	CrCbGaD
Etonogestrel—Levonorgestrel—ESR1—hematologic cancer	0.000143	0.0415	CrCbGaD
Etonogestrel—Methyltestosterone—AR—hematologic cancer	0.000142	0.0415	CrCbGaD
Etonogestrel—Danazol—ESR1—hematologic cancer	0.00013	0.0378	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ESR1—hematologic cancer	0.00012	0.035	CrCbGaD
Etonogestrel—Testosterone—SLC22A1—hematologic cancer	9.3e-05	0.0271	CrCbGaD
Etonogestrel—Testosterone—AR—hematologic cancer	8.26e-05	0.0241	CrCbGaD
Etonogestrel—Testosterone—ABCG2—hematologic cancer	6.5e-05	0.0189	CrCbGaD
Etonogestrel—Norethindrone—ALB—hematologic cancer	5.15e-05	0.015	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ABCB1—hematologic cancer	5.11e-05	0.0149	CrCbGaD
Etonogestrel—Norethindrone—ABCB1—hematologic cancer	4.91e-05	0.0143	CrCbGaD
Etonogestrel—Methyltestosterone—ALB—hematologic cancer	4.89e-05	0.0142	CrCbGaD
Etonogestrel—Testosterone—ALB—hematologic cancer	2.83e-05	0.00825	CrCbGaD
Etonogestrel—Testosterone—ABCB1—hematologic cancer	2.7e-05	0.00787	CrCbGaD
Etonogestrel—Rhinitis—Doxorubicin—hematologic cancer	2.19e-05	0.000117	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—hematologic cancer	2.19e-05	0.000117	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisolone—hematologic cancer	2.18e-05	0.000116	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—hematologic cancer	2.18e-05	0.000116	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—hematologic cancer	2.17e-05	0.000116	CcSEcCtD
Etonogestrel—Dyspepsia—Dexamethasone—hematologic cancer	2.17e-05	0.000116	CcSEcCtD
Etonogestrel—Dyspepsia—Betamethasone—hematologic cancer	2.17e-05	0.000116	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—hematologic cancer	2.16e-05	0.000115	CcSEcCtD
Etonogestrel—Urticaria—Triamcinolone—hematologic cancer	2.16e-05	0.000115	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Body temperature increased—Triamcinolone—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Oedema—Prednisone—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—hematologic cancer	2.15e-05	0.000115	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—hematologic cancer	2.14e-05	0.000115	CcSEcCtD
Etonogestrel—Decreased appetite—Dexamethasone—hematologic cancer	2.14e-05	0.000115	CcSEcCtD
Etonogestrel—Decreased appetite—Betamethasone—hematologic cancer	2.14e-05	0.000115	CcSEcCtD
Etonogestrel—Nausea—Irinotecan—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Etonogestrel—Nausea—Mitoxantrone—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—hematologic cancer	2.14e-05	0.000114	CcSEcCtD
Etonogestrel—Infection—Prednisone—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Fatigue—Betamethasone—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Fatigue—Dexamethasone—hematologic cancer	2.13e-05	0.000114	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—hematologic cancer	2.12e-05	0.000113	CcSEcCtD
Etonogestrel—Pain—Dexamethasone—hematologic cancer	2.11e-05	0.000113	CcSEcCtD
Etonogestrel—Pain—Betamethasone—hematologic cancer	2.11e-05	0.000113	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—hematologic cancer	2.11e-05	0.000113	CcSEcCtD
Etonogestrel—Nervous system disorder—Prednisone—hematologic cancer	2.11e-05	0.000113	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—hematologic cancer	2.09e-05	0.000112	CcSEcCtD
Etonogestrel—Skin disorder—Prednisone—hematologic cancer	2.09e-05	0.000112	CcSEcCtD
Etonogestrel—Nausea—Gemcitabine—hematologic cancer	2.08e-05	0.000111	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—hematologic cancer	2.08e-05	0.000111	CcSEcCtD
Etonogestrel—Mental disorder—Epirubicin—hematologic cancer	2.07e-05	0.000111	CcSEcCtD
Etonogestrel—Rash—Cisplatin—hematologic cancer	2.06e-05	0.00011	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—hematologic cancer	2.06e-05	0.00011	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—hematologic cancer	2.06e-05	0.00011	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—hematologic cancer	2.06e-05	0.00011	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—hematologic cancer	2.05e-05	0.00011	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—hematologic cancer	2.05e-05	0.000109	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—hematologic cancer	2.04e-05	0.000109	CcSEcCtD
Etonogestrel—Feeling abnormal—Betamethasone—hematologic cancer	2.03e-05	0.000109	CcSEcCtD
Etonogestrel—Feeling abnormal—Dexamethasone—hematologic cancer	2.03e-05	0.000109	CcSEcCtD
Etonogestrel—Flatulence—Epirubicin—hematologic cancer	2.03e-05	0.000108	CcSEcCtD
Etonogestrel—Tension—Epirubicin—hematologic cancer	2.02e-05	0.000108	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.02e-05	0.000108	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Betamethasone—hematologic cancer	2.02e-05	0.000108	CcSEcCtD
Etonogestrel—Hypersensitivity—Triamcinolone—hematologic cancer	2e-05	0.000107	CcSEcCtD
Etonogestrel—Nervousness—Epirubicin—hematologic cancer	2e-05	0.000107	CcSEcCtD
Etonogestrel—Back pain—Epirubicin—hematologic cancer	1.99e-05	0.000106	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—hematologic cancer	1.99e-05	0.000106	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—hematologic cancer	1.98e-05	0.000106	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—hematologic cancer	1.98e-05	0.000106	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—hematologic cancer	1.98e-05	0.000106	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—hematologic cancer	1.98e-05	0.000106	CcSEcCtD
Etonogestrel—Urticaria—Dexamethasone—hematologic cancer	1.96e-05	0.000105	CcSEcCtD
Etonogestrel—Urticaria—Betamethasone—hematologic cancer	1.96e-05	0.000105	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.96e-05	0.000105	CcSEcCtD
Etonogestrel—Dizziness—Prednisolone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Asthenia—Triamcinolone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Abdominal pain—Dexamethasone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Body temperature increased—Dexamethasone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Body temperature increased—Betamethasone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Abdominal pain—Betamethasone—hematologic cancer	1.95e-05	0.000104	CcSEcCtD
Etonogestrel—Nausea—Cisplatin—hematologic cancer	1.94e-05	0.000104	CcSEcCtD
Etonogestrel—Insomnia—Prednisone—hematologic cancer	1.94e-05	0.000104	CcSEcCtD
Etonogestrel—Alopecia—Doxorubicin—hematologic cancer	1.93e-05	0.000103	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisone—hematologic cancer	1.93e-05	0.000103	CcSEcCtD
Etonogestrel—Pruritus—Triamcinolone—hematologic cancer	1.92e-05	0.000103	CcSEcCtD
Etonogestrel—Cough—Methotrexate—hematologic cancer	1.92e-05	0.000103	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—hematologic cancer	1.92e-05	0.000102	CcSEcCtD
Etonogestrel—Ill-defined disorder—Epirubicin—hematologic cancer	1.91e-05	0.000102	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—hematologic cancer	1.91e-05	0.000102	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—hematologic cancer	1.91e-05	0.000102	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—hematologic cancer	1.9e-05	0.000102	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—hematologic cancer	1.9e-05	0.000102	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—hematologic cancer	1.89e-05	0.000101	CcSEcCtD
Etonogestrel—Rash—Etoposide—hematologic cancer	1.89e-05	0.000101	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—hematologic cancer	1.89e-05	0.000101	CcSEcCtD
Etonogestrel—Headache—Etoposide—hematologic cancer	1.88e-05	0.0001	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—hematologic cancer	1.88e-05	0.0001	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—hematologic cancer	1.87e-05	0.0001	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—hematologic cancer	1.87e-05	0.0001	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—hematologic cancer	1.87e-05	9.99e-05	CcSEcCtD
Etonogestrel—Decreased appetite—Prednisone—hematologic cancer	1.87e-05	9.98e-05	CcSEcCtD
Etonogestrel—Rash—Prednisolone—hematologic cancer	1.86e-05	9.96e-05	CcSEcCtD
Etonogestrel—Dermatitis—Prednisolone—hematologic cancer	1.86e-05	9.95e-05	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.86e-05	9.94e-05	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—hematologic cancer	1.86e-05	9.92e-05	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—hematologic cancer	1.85e-05	9.9e-05	CcSEcCtD
Etonogestrel—Headache—Prednisolone—hematologic cancer	1.85e-05	9.9e-05	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—hematologic cancer	1.85e-05	9.89e-05	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—hematologic cancer	1.85e-05	9.89e-05	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—hematologic cancer	1.84e-05	9.85e-05	CcSEcCtD
Etonogestrel—Constipation—Prednisone—hematologic cancer	1.84e-05	9.82e-05	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—hematologic cancer	1.83e-05	9.79e-05	CcSEcCtD
Etonogestrel—Dizziness—Triamcinolone—hematologic cancer	1.8e-05	9.61e-05	CcSEcCtD
Etonogestrel—Cough—Epirubicin—hematologic cancer	1.8e-05	9.6e-05	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—hematologic cancer	1.8e-05	9.6e-05	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—hematologic cancer	1.78e-05	9.53e-05	CcSEcCtD
Etonogestrel—Infection—Methotrexate—hematologic cancer	1.78e-05	9.53e-05	CcSEcCtD
Etonogestrel—Nausea—Etoposide—hematologic cancer	1.78e-05	9.52e-05	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—hematologic cancer	1.78e-05	9.5e-05	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisone—hematologic cancer	1.77e-05	9.46e-05	CcSEcCtD
Etonogestrel—Asthenia—Betamethasone—hematologic cancer	1.77e-05	9.46e-05	CcSEcCtD
Etonogestrel—Asthenia—Dexamethasone—hematologic cancer	1.77e-05	9.46e-05	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—hematologic cancer	1.77e-05	9.45e-05	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—hematologic cancer	1.76e-05	9.41e-05	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—hematologic cancer	1.76e-05	9.39e-05	CcSEcCtD
Etonogestrel—Nausea—Prednisolone—hematologic cancer	1.76e-05	9.39e-05	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—hematologic cancer	1.75e-05	9.37e-05	CcSEcCtD
Etonogestrel—Myalgia—Epirubicin—hematologic cancer	1.75e-05	9.37e-05	CcSEcCtD
Etonogestrel—Anxiety—Epirubicin—hematologic cancer	1.75e-05	9.33e-05	CcSEcCtD
Etonogestrel—Pruritus—Dexamethasone—hematologic cancer	1.75e-05	9.33e-05	CcSEcCtD
Etonogestrel—Pruritus—Betamethasone—hematologic cancer	1.75e-05	9.33e-05	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—hematologic cancer	1.74e-05	9.32e-05	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.74e-05	9.3e-05	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—hematologic cancer	1.73e-05	9.26e-05	CcSEcCtD
Etonogestrel—Vomiting—Triamcinolone—hematologic cancer	1.73e-05	9.24e-05	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—hematologic cancer	1.72e-05	9.18e-05	CcSEcCtD
Etonogestrel—Rash—Triamcinolone—hematologic cancer	1.71e-05	9.16e-05	CcSEcCtD
Etonogestrel—Dermatitis—Triamcinolone—hematologic cancer	1.71e-05	9.15e-05	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—hematologic cancer	1.71e-05	9.15e-05	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—hematologic cancer	1.71e-05	9.12e-05	CcSEcCtD
Etonogestrel—Headache—Triamcinolone—hematologic cancer	1.7e-05	9.1e-05	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—hematologic cancer	1.7e-05	9.08e-05	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—hematologic cancer	1.7e-05	9.08e-05	CcSEcCtD
Etonogestrel—Diarrhoea—Dexamethasone—hematologic cancer	1.69e-05	9.02e-05	CcSEcCtD
Etonogestrel—Diarrhoea—Betamethasone—hematologic cancer	1.69e-05	9.02e-05	CcSEcCtD
Etonogestrel—Anaphylactic shock—Epirubicin—hematologic cancer	1.68e-05	8.98e-05	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—hematologic cancer	1.68e-05	8.98e-05	CcSEcCtD
Etonogestrel—Infection—Epirubicin—hematologic cancer	1.67e-05	8.92e-05	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—hematologic cancer	1.66e-05	8.88e-05	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—hematologic cancer	1.65e-05	8.82e-05	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—hematologic cancer	1.65e-05	8.81e-05	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—hematologic cancer	1.64e-05	8.79e-05	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.64e-05	8.74e-05	CcSEcCtD
Etonogestrel—Skin disorder—Epirubicin—hematologic cancer	1.63e-05	8.72e-05	CcSEcCtD
Etonogestrel—Dizziness—Dexamethasone—hematologic cancer	1.63e-05	8.72e-05	CcSEcCtD
Etonogestrel—Dizziness—Betamethasone—hematologic cancer	1.63e-05	8.72e-05	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—hematologic cancer	1.62e-05	8.68e-05	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—hematologic cancer	1.62e-05	8.67e-05	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—hematologic cancer	1.62e-05	8.67e-05	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—hematologic cancer	1.62e-05	8.64e-05	CcSEcCtD
Etonogestrel—Nausea—Triamcinolone—hematologic cancer	1.61e-05	8.63e-05	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—hematologic cancer	1.61e-05	8.62e-05	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.61e-05	8.61e-05	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—hematologic cancer	1.6e-05	8.56e-05	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—hematologic cancer	1.6e-05	8.56e-05	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—hematologic cancer	1.6e-05	8.53e-05	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisone—hematologic cancer	1.58e-05	8.46e-05	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—hematologic cancer	1.58e-05	8.45e-05	CcSEcCtD
Etonogestrel—Vomiting—Betamethasone—hematologic cancer	1.57e-05	8.38e-05	CcSEcCtD
Etonogestrel—Vomiting—Dexamethasone—hematologic cancer	1.57e-05	8.38e-05	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—hematologic cancer	1.56e-05	8.34e-05	CcSEcCtD
Etonogestrel—Rash—Betamethasone—hematologic cancer	1.56e-05	8.31e-05	CcSEcCtD
Etonogestrel—Rash—Dexamethasone—hematologic cancer	1.56e-05	8.31e-05	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—hematologic cancer	1.55e-05	8.31e-05	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—hematologic cancer	1.55e-05	8.31e-05	CcSEcCtD
Etonogestrel—Dermatitis—Betamethasone—hematologic cancer	1.55e-05	8.31e-05	CcSEcCtD
Etonogestrel—Dermatitis—Dexamethasone—hematologic cancer	1.55e-05	8.31e-05	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.55e-05	8.28e-05	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—hematologic cancer	1.55e-05	8.27e-05	CcSEcCtD
Etonogestrel—Headache—Betamethasone—hematologic cancer	1.55e-05	8.26e-05	CcSEcCtD
Etonogestrel—Headache—Dexamethasone—hematologic cancer	1.55e-05	8.26e-05	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—hematologic cancer	1.54e-05	8.25e-05	CcSEcCtD
Etonogestrel—Asthenia—Prednisone—hematologic cancer	1.54e-05	8.24e-05	CcSEcCtD
Etonogestrel—Pain—Methotrexate—hematologic cancer	1.54e-05	8.21e-05	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.53e-05	8.18e-05	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—hematologic cancer	1.52e-05	8.15e-05	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—hematologic cancer	1.52e-05	8.12e-05	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—hematologic cancer	1.52e-05	8.12e-05	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—hematologic cancer	1.51e-05	8.07e-05	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—hematologic cancer	1.51e-05	8.06e-05	CcSEcCtD
Etonogestrel—Somnolence—Epirubicin—hematologic cancer	1.49e-05	7.98e-05	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—hematologic cancer	1.48e-05	7.92e-05	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—hematologic cancer	1.48e-05	7.91e-05	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—hematologic cancer	1.48e-05	7.9e-05	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—hematologic cancer	1.47e-05	7.86e-05	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—hematologic cancer	1.47e-05	7.85e-05	CcSEcCtD
Etonogestrel—Nausea—Betamethasone—hematologic cancer	1.47e-05	7.83e-05	CcSEcCtD
Etonogestrel—Nausea—Dexamethasone—hematologic cancer	1.47e-05	7.83e-05	CcSEcCtD
Etonogestrel—Decreased appetite—Epirubicin—hematologic cancer	1.46e-05	7.81e-05	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.45e-05	7.75e-05	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—hematologic cancer	1.45e-05	7.74e-05	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—hematologic cancer	1.44e-05	7.68e-05	CcSEcCtD
Etonogestrel—Pain—Epirubicin—hematologic cancer	1.44e-05	7.68e-05	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—hematologic cancer	1.43e-05	7.62e-05	CcSEcCtD
Etonogestrel—Dizziness—Prednisone—hematologic cancer	1.42e-05	7.59e-05	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—hematologic cancer	1.42e-05	7.59e-05	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—hematologic cancer	1.42e-05	7.59e-05	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.42e-05	7.57e-05	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—hematologic cancer	1.41e-05	7.51e-05	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—hematologic cancer	1.4e-05	7.46e-05	CcSEcCtD
Etonogestrel—Feeling abnormal—Epirubicin—hematologic cancer	1.38e-05	7.4e-05	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—hematologic cancer	1.38e-05	7.39e-05	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—hematologic cancer	1.37e-05	7.34e-05	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—hematologic cancer	1.37e-05	7.31e-05	CcSEcCtD
Etonogestrel—Vomiting—Prednisone—hematologic cancer	1.37e-05	7.3e-05	CcSEcCtD
Etonogestrel—Rash—Prednisone—hematologic cancer	1.35e-05	7.24e-05	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—hematologic cancer	1.35e-05	7.23e-05	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—hematologic cancer	1.35e-05	7.22e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—SYK—hematologic cancer	1.35e-05	0.000217	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HSP90AA1—hematologic cancer	1.35e-05	0.000217	CbGpPWpGaD
Etonogestrel—Headache—Prednisone—hematologic cancer	1.35e-05	7.19e-05	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.34e-05	7.17e-05	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—hematologic cancer	1.34e-05	7.16e-05	CcSEcCtD
Etonogestrel—Urticaria—Epirubicin—hematologic cancer	1.33e-05	7.13e-05	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—hematologic cancer	1.33e-05	7.11e-05	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—hematologic cancer	1.33e-05	7.11e-05	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—hematologic cancer	1.33e-05	7.1e-05	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—hematologic cancer	1.33e-05	7.1e-05	CcSEcCtD
Etonogestrel—PGR—Gene Expression—ESR1—hematologic cancer	1.33e-05	0.000214	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Methotrexate—hematologic cancer	1.32e-05	7.07e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—RGS2—hematologic cancer	1.32e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HDAC2—hematologic cancer	1.31e-05	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRH—hematologic cancer	1.3e-05	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CMA1—hematologic cancer	1.3e-05	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRIO—hematologic cancer	1.3e-05	0.000211	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT1—hematologic cancer	1.3e-05	0.00021	CbGpPWpGaD
Etonogestrel—Asthenia—Methotrexate—hematologic cancer	1.29e-05	6.88e-05	CcSEcCtD
Etonogestrel—PGR—Gene Expression—NOTCH1—hematologic cancer	1.28e-05	0.000207	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Doxorubicin—hematologic cancer	1.28e-05	6.85e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—AGO2—hematologic cancer	1.28e-05	0.000206	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPHK1—hematologic cancer	1.28e-05	0.000206	CbGpPWpGaD
Etonogestrel—Nausea—Prednisone—hematologic cancer	1.28e-05	6.82e-05	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.27e-05	6.79e-05	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—hematologic cancer	1.27e-05	6.79e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—HDAC9—hematologic cancer	1.26e-05	0.000204	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LPAR1—hematologic cancer	1.26e-05	0.000204	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—H3F3B—hematologic cancer	1.25e-05	0.000202	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Epirubicin—hematologic cancer	1.24e-05	6.62e-05	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—hematologic cancer	1.23e-05	6.6e-05	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—hematologic cancer	1.23e-05	6.57e-05	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—hematologic cancer	1.23e-05	6.57e-05	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—hematologic cancer	1.23e-05	6.57e-05	CcSEcCtD
Etonogestrel—CYP3A4—Metabolism—GMPS—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PHYH—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FTCD—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRB2—hematologic cancer	1.22e-05	0.000196	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFA—hematologic cancer	1.21e-05	0.000196	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—hematologic cancer	1.21e-05	6.44e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—KITLG—hematologic cancer	1.19e-05	0.000193	CbGpPWpGaD
Etonogestrel—Pruritus—Epirubicin—hematologic cancer	1.19e-05	6.35e-05	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—hematologic cancer	1.19e-05	6.35e-05	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.17e-05	0.00019	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT5A—hematologic cancer	1.17e-05	0.000189	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CNR2—hematologic cancer	1.16e-05	0.000188	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDE4B—hematologic cancer	1.16e-05	0.000188	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CREBBP—hematologic cancer	1.16e-05	0.000188	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—hematologic cancer	1.16e-05	0.000187	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF19—hematologic cancer	1.15e-05	0.000186	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—hematologic cancer	1.15e-05	6.14e-05	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—hematologic cancer	1.15e-05	6.12e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—RAC2—hematologic cancer	1.14e-05	0.000185	CbGpPWpGaD
Etonogestrel—Vomiting—Methotrexate—hematologic cancer	1.14e-05	6.1e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—DKK1—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AR—hematologic cancer	1.13e-05	0.000183	CbGpPWpGaD
Etonogestrel—Rash—Methotrexate—hematologic cancer	1.13e-05	6.05e-05	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—hematologic cancer	1.13e-05	6.04e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—STAT5B—hematologic cancer	1.13e-05	0.000182	CbGpPWpGaD
Etonogestrel—Headache—Methotrexate—hematologic cancer	1.12e-05	6.01e-05	CcSEcCtD
Etonogestrel—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.12e-05	0.000181	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD86—hematologic cancer	1.12e-05	0.000181	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—hematologic cancer	1.12e-05	5.96e-05	CcSEcCtD
Etonogestrel—Dizziness—Epirubicin—hematologic cancer	1.11e-05	5.94e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—HES1—hematologic cancer	1.1e-05	0.000178	CbGpPWpGaD
Etonogestrel—Pruritus—Doxorubicin—hematologic cancer	1.1e-05	5.88e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—NCOR1—hematologic cancer	1.1e-05	0.000177	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADCY7—hematologic cancer	1.09e-05	0.000177	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CSF2—hematologic cancer	1.09e-05	0.000175	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF1—hematologic cancer	1.09e-05	0.000175	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FOXO1—hematologic cancer	1.07e-05	0.000173	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRB—hematologic cancer	1.07e-05	0.000172	CbGpPWpGaD
Etonogestrel—Vomiting—Epirubicin—hematologic cancer	1.07e-05	5.71e-05	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—hematologic cancer	1.07e-05	5.7e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—XIAP—hematologic cancer	1.06e-05	0.000172	CbGpPWpGaD
Etonogestrel—Diarrhoea—Doxorubicin—hematologic cancer	1.06e-05	5.68e-05	CcSEcCtD
Etonogestrel—Rash—Epirubicin—hematologic cancer	1.06e-05	5.66e-05	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—hematologic cancer	1.06e-05	5.66e-05	CcSEcCtD
Etonogestrel—Headache—Epirubicin—hematologic cancer	1.05e-05	5.63e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—PDGFRA—hematologic cancer	1.05e-05	0.00017	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRKCG—hematologic cancer	1.05e-05	0.000169	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAK1—hematologic cancer	1.05e-05	0.000169	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—hematologic cancer	1.05e-05	0.000169	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SH2B3—hematologic cancer	1.04e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMARCA4—hematologic cancer	1.04e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GZMB—hematologic cancer	1.03e-05	0.000166	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—hematologic cancer	1.03e-05	5.49e-05	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—CTNNA1—hematologic cancer	1.01e-05	0.000162	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EIF4EBP1—hematologic cancer	1e-05	0.000161	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HSPB1—hematologic cancer	1e-05	0.000161	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL3—hematologic cancer	1e-05	0.000161	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—hematologic cancer	9.98e-06	5.33e-05	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—NCOR1—hematologic cancer	9.91e-06	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTHLH—hematologic cancer	9.89e-06	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SDC1—hematologic cancer	9.89e-06	0.00016	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—hematologic cancer	9.88e-06	5.28e-05	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—hematologic cancer	9.8e-06	5.24e-05	CcSEcCtD
Etonogestrel—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.79e-06	0.000158	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DCK—hematologic cancer	9.79e-06	0.000158	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ASNS—hematologic cancer	9.79e-06	0.000158	CbGpPWpGaD
Etonogestrel—Dermatitis—Doxorubicin—hematologic cancer	9.79e-06	5.23e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—IL2RA—hematologic cancer	9.79e-06	0.000158	CbGpPWpGaD
Etonogestrel—Headache—Doxorubicin—hematologic cancer	9.74e-06	5.21e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—TERT—hematologic cancer	9.68e-06	0.000156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTGER4—hematologic cancer	9.63e-06	0.000155	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LCK—hematologic cancer	9.58e-06	0.000155	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFB—hematologic cancer	9.45e-06	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—H3F3A—hematologic cancer	9.39e-06	0.000152	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HDC—hematologic cancer	9.28e-06	0.00015	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—hematologic cancer	9.23e-06	4.94e-05	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—TSC2—hematologic cancer	9.23e-06	0.000149	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR3C1—hematologic cancer	9.17e-06	0.000148	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCZ—hematologic cancer	9.13e-06	0.000147	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR3—hematologic cancer	8.88e-06	0.000143	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PARP1—hematologic cancer	8.81e-06	0.000142	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK14—hematologic cancer	8.79e-06	0.000142	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FBXW7—hematologic cancer	8.67e-06	0.00014	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—hematologic cancer	8.63e-06	0.000139	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FN1—hematologic cancer	8.52e-06	0.000138	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR4—hematologic cancer	8.5e-06	0.000137	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HDAC2—hematologic cancer	8.5e-06	0.000137	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CDA—hematologic cancer	8.49e-06	0.000137	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BAD—hematologic cancer	8.42e-06	0.000136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFKBIA—hematologic cancer	8.42e-06	0.000136	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—hematologic cancer	8.41e-06	0.000136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—hematologic cancer	8.34e-06	0.000135	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CBL—hematologic cancer	8.29e-06	0.000134	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL3—hematologic cancer	8.2e-06	0.000132	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PC—hematologic cancer	8.17e-06	0.000132	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CD80—hematologic cancer	8.17e-06	0.000132	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—hematologic cancer	8.15e-06	0.000132	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—hematologic cancer	8.15e-06	0.000132	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTPN1—hematologic cancer	8.06e-06	0.00013	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTPN11—hematologic cancer	8.01e-06	0.000129	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK14—hematologic cancer	7.94e-06	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RASGRP1—hematologic cancer	7.93e-06	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HSP90AA1—hematologic cancer	7.91e-06	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SYK—hematologic cancer	7.91e-06	0.000128	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GBA—hematologic cancer	7.89e-06	0.000127	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.89e-06	0.000127	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREB1—hematologic cancer	7.76e-06	0.000125	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—hematologic cancer	7.66e-06	0.000124	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT1—hematologic cancer	7.62e-06	0.000123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL2—hematologic cancer	7.59e-06	0.000123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6R—hematologic cancer	7.57e-06	0.000122	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREBBP—hematologic cancer	7.56e-06	0.000122	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—hematologic cancer	7.53e-06	0.000122	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTAP—hematologic cancer	7.22e-06	0.000117	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAP2K1—hematologic cancer	7.22e-06	0.000116	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—hematologic cancer	7.17e-06	0.000116	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRB2—hematologic cancer	7.13e-06	0.000115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFA—hematologic cancer	7.11e-06	0.000115	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—hematologic cancer	7.09e-06	0.000115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KITLG—hematologic cancer	7.01e-06	0.000113	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—hematologic cancer	6.9e-06	0.000111	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGF2—hematologic cancer	6.86e-06	0.000111	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT5A—hematologic cancer	6.85e-06	0.000111	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CREBBP—hematologic cancer	6.82e-06	0.00011	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	6.79e-06	0.00011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3R1—hematologic cancer	6.77e-06	0.000109	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAK2—hematologic cancer	6.58e-06	0.000106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD86—hematologic cancer	6.57e-06	0.000106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HES1—hematologic cancer	6.48e-06	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCOR1—hematologic cancer	6.44e-06	0.000104	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FHL2—hematologic cancer	6.44e-06	0.000104	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDM2—hematologic cancer	6.42e-06	0.000104	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CSF2—hematologic cancer	6.37e-06	0.000103	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF1—hematologic cancer	6.37e-06	0.000103	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AGRN—hematologic cancer	6.31e-06	0.000102	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FOXO1—hematologic cancer	6.28e-06	0.000101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	6.27e-06	0.000101	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MTOR—hematologic cancer	6.25e-06	0.000101	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—hematologic cancer	6.25e-06	0.000101	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	6.17e-06	9.96e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCG—hematologic cancer	6.15e-06	9.93e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAK1—hematologic cancer	6.15e-06	9.93e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMMR—hematologic cancer	5.98e-06	9.66e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH2—hematologic cancer	5.98e-06	9.66e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—hematologic cancer	5.86e-06	9.47e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—hematologic cancer	5.75e-06	9.28e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2RA—hematologic cancer	5.74e-06	9.27e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—hematologic cancer	5.74e-06	9.26e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—hematologic cancer	5.68e-06	9.17e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.63e-06	9.08e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—hematologic cancer	5.59e-06	9.03e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUN—hematologic cancer	5.58e-06	9.01e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFB—hematologic cancer	5.54e-06	8.95e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACP5—hematologic cancer	5.47e-06	8.83e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA9—hematologic cancer	5.47e-06	8.83e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TSC2—hematologic cancer	5.42e-06	8.75e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—hematologic cancer	5.41e-06	8.74e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.4e-06	8.72e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—hematologic cancer	5.4e-06	8.72e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK8—hematologic cancer	5.28e-06	8.53e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR3—hematologic cancer	5.21e-06	8.42e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK14—hematologic cancer	5.16e-06	8.33e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—hematologic cancer	5.15e-06	8.31e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—IDH1—hematologic cancer	5.14e-06	8.31e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TXN—hematologic cancer	5.09e-06	8.21e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.09e-06	8.21e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.09e-06	8.21e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—hematologic cancer	5.01e-06	8.08e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FN1—hematologic cancer	5e-06	8.07e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.98e-06	8.04e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BAD—hematologic cancer	4.94e-06	7.98e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	4.94e-06	7.98e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	4.89e-06	7.9e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—hematologic cancer	4.88e-06	7.87e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—hematologic cancer	4.83e-06	7.8e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—hematologic cancer	4.82e-06	7.78e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CD80—hematologic cancer	4.79e-06	7.74e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	4.79e-06	7.73e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—hematologic cancer	4.79e-06	7.73e-05	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—hematologic cancer	4.79e-06	7.73e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.78e-06	7.72e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTPN11—hematologic cancer	4.7e-06	7.59e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.65e-06	7.51e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.65e-06	7.51e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—hematologic cancer	4.61e-06	7.45e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREB1—hematologic cancer	4.56e-06	7.35e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.53e-06	7.32e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—hematologic cancer	4.5e-06	7.26e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—hematologic cancer	4.49e-06	7.24e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—hematologic cancer	4.48e-06	7.23e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL2—hematologic cancer	4.46e-06	7.2e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6R—hematologic cancer	4.44e-06	7.17e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREBBP—hematologic cancer	4.44e-06	7.16e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NUP98—hematologic cancer	4.39e-06	7.09e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.26e-06	6.88e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.26e-06	6.88e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	4.23e-06	6.84e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NUP214—hematologic cancer	4.23e-06	6.83e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	4.21e-06	6.79e-05	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—hematologic cancer	4.16e-06	6.72e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.15e-06	6.7e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTR—hematologic cancer	4.15e-06	6.7e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—hematologic cancer	4.15e-06	6.69e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO2—hematologic cancer	4.07e-06	6.57e-05	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—hematologic cancer	4.05e-06	6.54e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGF2—hematologic cancer	4.03e-06	6.5e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	3.97e-06	6.41e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.94e-06	6.37e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAK2—hematologic cancer	3.86e-06	6.23e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SDC1—hematologic cancer	3.86e-06	6.22e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—hematologic cancer	3.81e-06	6.15e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDM2—hematologic cancer	3.77e-06	6.08e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—hematologic cancer	3.68e-06	5.95e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTOR—hematologic cancer	3.67e-06	5.92e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	3.67e-06	5.92e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—hematologic cancer	3.52e-06	5.69e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	3.44e-06	5.56e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—hematologic cancer	3.37e-06	5.45e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—hematologic cancer	3.37e-06	5.45e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—hematologic cancer	3.37e-06	5.44e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—hematologic cancer	3.28e-06	5.3e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NQO1—hematologic cancer	3.28e-06	5.29e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CD44—hematologic cancer	3.28e-06	5.29e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUN—hematologic cancer	3.28e-06	5.29e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	3.18e-06	5.13e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—hematologic cancer	3.17e-06	5.12e-05	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—hematologic cancer	3.11e-06	5.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYCS—hematologic cancer	3.1e-06	5.01e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK8—hematologic cancer	3.1e-06	5e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	4.98e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—hematologic cancer	3.02e-06	4.88e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—hematologic cancer	2.94e-06	4.74e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—hematologic cancer	2.86e-06	4.62e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—hematologic cancer	2.83e-06	4.58e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—hematologic cancer	2.83e-06	4.56e-05	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—hematologic cancer	2.81e-06	4.53e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.73e-06	4.41e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—hematologic cancer	2.71e-06	4.37e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—hematologic cancer	2.63e-06	4.25e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—hematologic cancer	2.63e-06	4.24e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.59e-06	4.18e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.51e-06	4.06e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.51e-06	4.06e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—hematologic cancer	2.43e-06	3.93e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	2.24e-06	3.61e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.22e-06	3.58e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—hematologic cancer	2.16e-06	3.49e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—hematologic cancer	2.07e-06	3.34e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—hematologic cancer	1.98e-06	3.2e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.87e-06	3.01e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—hematologic cancer	1.83e-06	2.95e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.79e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.65e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—hematologic cancer	1.62e-06	2.61e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.5e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.43e-06	2.31e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—hematologic cancer	1.24e-06	1.99e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—hematologic cancer	1.18e-06	1.9e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.71e-07	1.41e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—hematologic cancer	7.12e-07	1.15e-05	CbGpPWpGaD
